NCATS's common goal with the FDA is to bring safe and effective drugs, regimens and devices from the bench to the bedside as quickly and efficiently as possible. Scientists who are knowledgeable about both preclinical translational science and regulatory science can help to achieve this goal.
To develop scientists with these essential skills, NCATS created the Translational Science Interagency Fellowship (TSIF) program. This initiative provides training opportunities at both NCATS and FDA. By combining training in translational science and research-related regulatory review, the TSIF program enables fellows to build awareness of regulatory requirements into the early stages of medical product development, improving efficiencies in both the development and review processes. Fellows develop valuable skills applicable to future careers in academia, the pharmaceutical industry and government.
Applications are now being accepted until February 3, 2025 at 11:59 p.m. EST
Julie Johnson, PharmD, is the Director and Principal Investigator at The Ohio State University Clinical and Translational Science Institute.